Skip to main content
Translational Behavioral Medicine logoLink to Translational Behavioral Medicine
. 2020 Nov 17;10(6):1399–1405. doi: 10.1093/tbm/ibaa115

Clinical management of emotions in patients with cancer: introducing the approach “emotional support and case finding”

Joost Dekker 1,, Jeanet Karchoud 1, Annemarie M J Braamse 2, Hilde Buiting 1, Inge R H M Konings 3, Myra E van Linde 3, Claudia S E W Schuurhuizen 4, Mirjam A G Sprangers 2, Aartjan T F Beekman 1, Henk M W Verheul 5
PMCID: PMC7796719  PMID: 33200793

Patients with chronic conditions will benefit from interventions that are personalized to their needs and account for barriers that make adherence difficult for them, such as patients’ beliefs.

Keywords: Emotions, Distress, Support, Screening, Case finding, Cancer

Abstract

The current approach to the management of emotions in patients with cancer is “distress screening and referral for the provision of psychosocial care.” Although this approach may have certain beneficial effects, screening and referral programs have shown a limited effect on patient psychological well-being. We argue that this limited effect is due to a mismatch between patient needs and the provision of care, and that a fundamental reconceptualization of the clinical management of emotions in patients with cancer is needed. We describe the rationale and characteristics of “emotional support and case finding” as the approach to the management of emotions in patients with cancer. The two main principles of the approach are: (1) Emotional support: (a) The treating team, consisting of doctors, nurses, and allied health staff, is responsive to the emotional needs of patients with cancer and provides emotional support. (b) The treating team provides information on external sources of emotional support. (2) Case finding: The treating team identifies patients in need of mental health care by means of case finding, and provides a referral to mental health care as indicated. We present a novel perspective on how to organize the clinical management of emotions in patients with cancer. This is intended to contribute to a fruitful discussion and to inform an innovative research agenda on how to manage emotions in patients with cancer.

DISTRESS SCREENING AND REFERRAL PROGRAMS

Distress refers to “a multifactorial unpleasant emotional experience of a psychological (i.e. cognitive, behavioral, emotional), social, and/or spiritual nature that may interfere with the ability to cope effectively with cancer, its physical symptoms, or its treatment” [1]. The term “distress” was introduced because it was considered to be more acceptable and less stigmatizing than psychiatric and psychological terminology [2]. Alternatively, traditional psychiatric diagnostic categories can be used to describe patients’ mental response to the diagnosis and treatment of cancer. The primary focus is usually on anxiety and mood disorders; occasionally, other mental disorders are included as well [3]. Distress is very common among patients with cancer, irrespective of terminology, underlying theory, and associated assessment. In patients in the active anti-tumor phase of treatment, reported prevalence rates are 18% for anxiety or mood disorders [4], 30%–40% for any combination of anxiety, mood, or adjustment disorders [5], 32% for any mental disorder [3], and 35%–52% for general distress [6, 7]. The identification and treatment of distress are a clinical priority because distress is a risk factor for non-adherence to medical treatment [8] and for a poor outcome in the physical, mental, and social life domains [9].

Currently, “distress screening and referral for the provision of psychosocial care” is the dominant approach to the management of distress. This approach comprises the identification of distress by means of a distress-screening tool, provision of support by the treating team in case of mild distress, and referral to psychosocial care for patients with moderate or severe distress [1]. Guidelines issued in a broad range of countries recommend distress screening and referral to psychosocial care in patients with cancer [1, 10–13]. This approach may indeed have certain beneficial effects (e.g., identification of distressed patients, or more doctor–patient communication about distress [14, 15]). However, screening and referral programs have shown a limited effect on patient psychological well-being [16–19]. A recent Cochrane review concluded that, although the certainty of the evidence is low and intervention and study characteristics were heterogeneous, the evidence does not support the effectiveness of screening of psychosocial well-being and care needs in patients with cancer [17]. Two recent studies not yet included in previous reviews reported similar results. In our recent randomized trial, we examined the outcome of a screening and referral program to identify and treat psychological distress in patients with metastasized colorectal cancer, comparing outcomes to usual care [16, 20]. We carefully created optimal conditions to ensure that the screening and referral program would be maximally effective. Nevertheless, the screening and referral program did not result in a reduction in psychological distress [16]. Another recent trial also failed to demonstrate a beneficial effect on global quality of life [21]. It should be noted that treatment of psychological distress per se is effective [22]; it is the current approach to identifying patients in need of treatment (i.e., distress screening and referral) which generally had a limited effect on psychological well-being.

A common response to these findings has been to advocate better implementation of screening and referral programs [23–30]. For example, use of an effective change management strategy, leadership, integration, customization, project management, and program evaluation has been recommended [23]. Other researchers have noted the heterogeneity in definitions and theoretical conceptualizations of distress, procedures for screening and referral, interventions, and outcomes [17, 30, 31]. This heterogeneity may have obscured beneficial effects of screening and referral programs. Beneficial effects could become discernible once the various features of the screening approaches are carefully disentangled. Although well intended, we believe that such efforts are unlikely to be effective. The main reason is that many patients with cancer are unwilling to accept a referral for psychosocial care and we believe that this is due to a mismatch between patient needs and the provision of care.

In our own study [16], 60% of patients showed elevated distress during at least one of the screening time points. Nevertheless, only 15% chose watchful waiting and a mere 11% accepted active mental health care (consisting of guided self-help, face-to-face problem-solving therapy, or a referral to professional mental health care). This low uptake of mental health care resulted in the screening and referral arm of the trial showing no improvement of psychological distress compared to the usual care arm. Low uptake of psychosocial care has been observed in several studies, in a range of countries and in several clinical settings [32]. In a UK-based study, only 36% of patients with elevated distress scores indicated a need for professional help with emotional problems [33]. An Australian study found that only 30% of distressed patients reported a need for help with distress [34]. In a USA-based study, screening was implemented to identify patients with distress: of the patients who screened positive for distress, only 14% had actually completed at least one appointment with the supportive care team after 14 days follow-up [35]. Finally, in a review of barriers to the delivery of psychosocial care in patients with cancer “no need for psychosocial services and support” was the most frequently reported barrier (reported by 39% of patients) [36]. Low uptake of psychosocial care, thus, seems to be a universal phenomenon. In view of this fact, we are skeptical that better implementation would result in effective programs for distress screening and referral. We would argue that a fundamental reconceptualization of the management of distress in patients with cancer seems to be warranted.

EMOTIONS

Distress is defined as an “unpleasant emotional experience” [1]. Distress refers to emotions and negative emotions in particular. For reasons of clarity, in the remainder of the paper, we will use the term “emotions.” These include negative emotions such as fear, anxiety, depression, and hostility, but also positive emotions such as happiness, hope, and calmness.

Human emotions have developed through the course of evolution because they facilitate adaptation to important events [37]. Emotions alert, motivate and prepare us to deal with these events [38]. For example, fear causes cognitive, behavioral, and physiological changes which help to face a threatening event [37]. Sadness turns our attention inwards, promoting resignation and acceptance. The expression of sadness may elicit sympathy and support from other people [39]. Emotions are essentially adaptive—they help us to adapt to events in the environment, such as the diagnosis and treatment of cancer [32]. In contrast, emotions sometimes hamper adaptation, leading to significant distress and disability [40]. Emotions are maladaptive if they are disproportionally severe or persistent, and if they interfere with functioning. Examples include severe anxiety leading to the avoidance of cancer treatment, depression leading to unrealistic negative expectations and lack of motivation to continue treatment, or fear of death leading to unrealistic optimism regarding the outcome of further treatment.

Identification of patients with clinically relevant distress is usually based on the intensity of emotional responses. The Distress Thermometer and other questionnaires use a cutoff score for the intensity of emotions; if patients score above the cutoff, they are considered to be distressed [1]. The underlying assumption is that a low intensity of emotions is to be preferred, that is, “less is better” [32]. The question arises whether this assumption is correct. Indeed, some patients scoring above the cutoff may experience maladaptive emotions. However, other patients scoring above the cutoff may actually experience adaptive emotions which facilitate coping with cancer. In general, a strong emotional experience in response to cancer is natural and potentially adaptive. Thus, equating an intense emotion with a maladaptive emotion is not a valid approach. Further research is needed to identify indicators that can differentiate between adaptive and maladaptive emotions in patients with cancer [41]. Psychological and psychiatric theories on emotions and mental disorders may guide the development of operational indicators that can distinguish between adaptive and maladaptive emotions, in addition to clinical criteria [40] and a patient’s personal evaluation of their own emotions. For example, the theory on emotion dynamics predicts that patients with maladaptive emotions are characterized by emotional symptoms that linger and perpetuate more across time, are more extreme, or are more unstable, compared to patients with adaptive emotions [42]. If confirmed in patients with cancer, an operational indicator could be developed to assess whether emotions are lingering, extreme, or unstable (instead of whether emotions are intense).

MATCHING THE PROVISION OF CARE TO PATIENTS’ NEEDS

We believe that the low uptake of mental health care is due to a mismatch between patient needs and the provision of care [32]. Patients experiencing adaptive emotions are expected to prefer to handle their emotions themselves [43–46]. They may welcome support from relatives, friends, peers, and primary care-givers (i.e., doctors and nurses). Patients with adaptive emotions can be expected to refuse a referral to mental health care; that is, care that primarily focuses on treating emotional problems. In contrast, professional mental health care such as psychotherapy or pharmacotherapy is indicated only in patients experiencing maladaptive emotions [47, 48]. We believe that matching the provision of care to the nature of emotions is in line with patients’ emotional needs: supportive interventions in case of adaptive emotions, and professional mental health care in case of maladaptive emotions [32].

EMOTIONAL SUPPORT AND CASE FINDING

These considerations regarding emotions, and matching of care to the nature of emotions (adaptive vs. maladaptive emotions) rather than the intensity of emotions, have led us to propose a new approach to the management of emotions in patients with cancer. We call this approach “emotional support and case finding” (see Box 1).

Implications.

Practice: The role of the treating team in the management of emotions in patients with cancer is pivotal. Mental health professionals mainly have an indirect role: they work through the treating team. Direct treatment occurs only in selected patients.

Policy: We recommend to revise existing guidelines, based on this approach.

Research: This approach informs an innovative research agenda on how to improve the clinical management of emotions in patients with cancer.

Box 1. Approach to the clinical management of cancer-related emotions: Emotional support and case finding.

  1. Emotional support

  2. The treating team consisting of doctors, nurses, and allied health staff is responsive to the emotional needs of patients with cancer and provides emotional support.

  3. The treating team provides information on external sources of emotional support.

  4. Case finding

The treating team identifies patients in need of mental health care by means of case finding, and provides a referral to mental health care as indicated.

Emotional support

Cancer is a life-threatening disease, its treatment is demanding and burdensome, it is associated with powerful emotions, and approximately one-third of patients fulfill the criteria of a mental disorder [3] or experience distress [6]. Nevertheless, the majority of patients with cancer display resilience: they adapt and are able to cope with cancer. In this respect, cancer resembles other potentially traumatic events: in the face of such events, humans are remarkably resilient and most people maintain an ability to function effectively [49].

However, the fact that patients are resilient does not mean that they have no need for support. In contrast, patients may need emotional support from relatives, friends, and peers [50–53], as well as the treating team consisting of doctors, nurses, and allied health staff. A recent study reported that patients perceived the treating team as an important source of emotional support [54], and patients felt that the treating team understood the burden of disease, so that they felt no need to explain the impact of disease [54]. Patients valued care that was provided with empathy and in accordance with their wishes [54]. In our own trial, we observed that enhanced discussion of psychosocial concerns by nurses and oncologists improved patient well-being [16].

Oncologists recognize the provision of emotional support as an important clinical task. It is one of the reasons why oncologists are passionate about oncology care [55]. Oncologists consider an emotional response to be a normal and natural reaction to receiving a cancer diagnosis or being treated for cancer [56], and report that they respond to their patient’s emotions by establishing a supportive relationship, normalizing the patient’s experience, calming the patient, and maintaining continuity of care [57]. Similarly, nurses consider delivery of emotional care and support to patients and their families a major component of their work [58].

Emotional support can also be provided by other means, including online self-management support [59], patient discussion and support groups (peers), and expert volunteers [60]. As patients are frequently unaware of these resources [36], information on these external resources should be made more readily available.

These considerations lead us to propose the first principle of the new approach, referred to as “emotional support”: (a) The treating team consisting of doctors, nurses, and allied health staff is responsive to the emotional needs of patients with cancer and provides emotional support. (b) The treating team provides information on external sources of emotional support.

Case finding

Some patients with cancer will experience maladaptive emotions, leading to the need for mental health care. As argued above, screening is unlikely to be an effective approach toward the identification of patients in need of mental health care. We propose that, in place of screening, case finding can be used to identify patients in need of mental health care [61]. Case finding is to be distinguished from screening, both conceptually and operationally. Screening is defined as “the application of a diagnostic test or clinical assessment in order to optimally rule-out those without the disorder with minimal false negatives (missed cases). Screening is often performed in a large population as the first of several diagnostic tests. (...) Case finding <is> the application of a diagnostic test or clinical assessment in order to optimally identify those with the disorder with minimal false positives (…). Case finding is often performed in a selected population at high risk for the condition” (p. 150) [62, 63]. In the present context, case finding is the purposive identification of patients with emotional problems for which a referral for mental health care is indicated. Risk factors for emotional problems in patients with cancer are well established. For example, younger age, lack of social support, and a relatively burdensome disease or treatment trajectory are well-known risk factors for distress [64, 65]. These risk factors warrant a clinical examination for case finding. We propose “case finding” as the second principle of the new approach: The treating team identifies patients in need of mental health care by means of case finding, and provides a referral to mental health care as indicated.

CONSIDERATIONS REGARDING THE APPROACH

Above, we have presented a dichotomous view of emotions: adaptive versus maladaptive. This is a simplification, as no absolute distinction between adaptive and maladaptive emotions exists. However, in clinical practice one needs to make a binary decision: to refer or not to refer the patient for the provision of mental health care. For that reason, we distinguish between adaptive emotions (no referral needed) and maladaptive emotions (referral needed).

Previous studies have demonstrated a disconnect between clinician-rated and patient-reported emotions [66–68]. However, doctors and nurses may be more sensitive to patients’ need for mental health care than previously reported. In a recent study, we assumed that doctors and nurses intuitively distinguish between adaptive emotions that do not require mental health care and maladaptive emotions that do require mental health care. This led us to hypothesize that the sensitivity of assessment of emotions by doctors and nurses would be higher when tested against patients’ need for mental health care as a reference standard, compared to patients’ emotional distress as a reference standard. This hypothesis was indeed confirmed [69]. This finding suggests that the clinical assessment of emotions in patients with cancer may be more accurate than previously reported.

Nevertheless, the accuracy of case finding may need to be optimized. Training of the members of the team may improve the accuracy of the identification of emotional problems. Oncologists and nurses have been observed to use various strategies to identify patients in need of mental health care. These include inquiring directly, getting to know the patient, using intuition and subjective judgment, and checking the patient’s medical history [56, 70]. Both doctors and nurses have indicated a need for further training in the identification of emotional problems [56, 70]. Training may thus improve the accuracy of case finding. Topics could include criteria for emotions to be considered maladaptive (e.g., interference with doctor–patient communication or functioning in daily life), risk factors for emotional problems, communication strategies to evaluate emotions, and cultural variations in the presentation of emotional problems.

The approach presented here is a proposal on how to organize care for emotions in patients with cancer. In this approach, the role of the treating team in the management of emotions in patients with cancer is pivotal. An important task for psychologists and other mental health professionals is to provide training to the treating team in applying this approach: training in providing emotional support, in differentiating adaptive from maladaptive emotions, in identifying patients in need of mental health care, and in motivating selected patients to accept a referral for mental health care. In some cases, mental health professionals provide treatment to patients with maladaptive emotions. However, psychologists and other mental health professionals mainly have an indirect role: they work through the treating team; direct treatment occurs only in selected patients (for a similar approach towards exercise therapy see [71]).

“Emotional support and case finding” constitutes a novel perspective on how to organize the clinical management of emotions in patients with cancer. As such, neither support nor case finding is new. The novelty of this approach lies in clearly articulating this approach and providing a rationale for this approach. This represents a significant improvement on current clinical practice: instead of poorly defined and intuitive usual care, we now present an explicit approach to the management of emotions in patients with cancer and we provide the rationale for this approach. This provides a backbone to current clinical practice, the approach can be used to upgrade clinical practice, and it informs an innovative research agenda (see below).

Furthermore, the fact that our approach is rather close to current clinical practice may facilitate implementation. Oncologists and nurses recognize the provision of emotional support as an important clinical task and they have been observed to use various strategies to identify patients in need of mental health care, as mentioned above. This is an important stepping-stone for successful implementation.

Finally, our approach could contribute to the prevention of poor clinical outcomes. The provision of emotional support by the treating team is intended to enable patients to better adapt and cope with cancer. This may prevent emotions from becoming maladaptive, requiring professional mental health care. In addition, improved management of emotions may prevent non-adherence to medical treatment and the associated poorer treatment outcomes [8].

FUTURE RESEARCH

The approach “emotional support and case finding” informs an innovative research agenda to further improve clinical practice. We suggest the following research agenda.

  • To explore the training needs of the treating team, and to develop effective and feasible training methods. Training may concern the assessment of emotions and the provision of emotional support.

  • To identify risk factors for emotional problems and to target case finding to those patients exhibiting risk factors (e.g., lack of social support, an earlier episode of depression).

  • To develop measurement instruments that can distinguish between adaptive and maladaptive emotions. These instruments should support and improve decision making that currently is based on clinical evaluation and patient’s subjective need only.

  • To optimize interventions to support patients with adaptive emotions as well as interventions to treat emotional problems in patients with maladaptive emotions. Such interventions are available, but may need further optimization.

  • To explore other factors that may influence the successful implementation of the new approach. For example, although oncologists and nurses recognize the provision of emotional support as an important clinical task, in a busy clinic time to perform these tasks is limited. How the treating team might perform the proposed tasks within the constraints of daily clinical practice needs to be investigated. In studying factors that may influence the successful implementation of the new approach, international variation in the organization of supportive cancer care needs to be taken into account as well.

  • And finally, to evaluate the extent to which clinical practice based on the new approach leads to enhanced health outcomes.

In conclusion, the approach “emotional support and case finding” provides a novel perspective on how to organize the clinical management of emotions in patients with cancer. This approach can be used to upgrade clinical practice, and it informs an innovative research agenda on how to further improve clinical practice.

Funding

No specific funding.

Compliance with Ethical Standards

Conflict of Interest All authors declare that they have no conflicts of interest.

Human Rights This article does not contain any studies with human participants performed by any of the authors.

Informed Consent This study does not involve human participants and informed consent was therefore not required.

Welfare of Animals This article does not contain any studies with animals performed by any of the authors.

References

  • 1. National Comprehensive Cancer Network  .  Guideline Distress Management Version 1.2019. Plymouth Meeting, PA: NCCN; ; 2019. [Google Scholar]
  • 2. Holland JC. History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med. 2002;64(2):206–221. [DOI] [PubMed] [Google Scholar]
  • 3. Mehnert A, Brähler E, Faller H, et al.  Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–3546. [DOI] [PubMed] [Google Scholar]
  • 4. Nakash O, Levav I, Aguilar-Gaxiola S, et al.  Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psychooncology. 2014;23(1):40–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Mitchell AJ, Chan M, Bhatti H, et al.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174. [DOI] [PubMed] [Google Scholar]
  • 6. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28. [DOI] [PubMed] [Google Scholar]
  • 7. Mehnert A, Hartung TJ, Friedrich M, et al.  One in two cancer patients is significantly distressed: Prevalence and indicators of distress. Psychooncology. 2018;27(1):75–82. [DOI] [PubMed] [Google Scholar]
  • 8. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–2107. [DOI] [PubMed] [Google Scholar]
  • 9. Lynch BM, Steginga SK, Hawkes AL, Pakenham KI, Dunn J. Describing and predicting psychological distress after colorectal cancer. Cancer. 2008;112(6):1363–1370. [DOI] [PubMed] [Google Scholar]
  • 10. American College of Surgeons Commission on Cancer. Cancer program standards: ensuring patient-centered care manual—Standard 3.2—psychosocial distress screening. Chicago, IL: American College of Surgeons; 2016: 56–57. [Google Scholar]
  • 11. Cancer Control Continuum—Screening for Distress. Available at https://ncci.canceraustralia.gov.au/psychosocial-care/screening-distress. Accessibility verified August 1, 2019.
  • 12. Pan-Canadian Practice Guideline. Screening, assessment and management of psychosocial distress, depression and anxiety in adults with cancer. Available at https://www.partnershipagainstcancer.ca/db-sage/sage20161035/. Accessibility verified August 1, 2019.
  • 13. Detecteren behoefte psychosociale zorg. Available at https://www.oncoline.nl/detecteren-behoefte-psychosociale-zorg. Accessibility verified August 1, 2019.
  • 14. Caruso R, Nanni MG, Riba M, et al.  Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol. 2017;56(2):146–155. [DOI] [PubMed] [Google Scholar]
  • 15. Mitchell AJ. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013;52(2):216–224. [DOI] [PubMed] [Google Scholar]
  • 16. Schuurhuizen CSEW, Braamse AMJ, Beekman ATF, et al.  Screening and stepped care targeting psychological distress in patients with metastatic colorectal cancer: the TES cluster randomized trial. J Natl Compr Canc Netw. 2019;17(8):911–920. [DOI] [PubMed] [Google Scholar]
  • 17. Schouten B, Avau B, Bekkering GTE, et al.  Systematic screening and assessment of psychosocial well-being and care needs of people with cancer. Cochrane Database Syst Rev. 2019;3:CD012387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Meijer A, Roseman M, Delisle VC, et al.  Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res. 2013;75(1):1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kotronoulas G, Kearney N, Maguire R, et al.  What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–1501. [DOI] [PubMed] [Google Scholar]
  • 20. Schuurhuizen CS, Braamse AM, Beekman AT, et al.  Screening and treatment of psychological distress in patients with metastatic colorectal cancer: study protocol of the TES trial. BMC Cancer. 2015;15:302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ploos van Amstel FK, Peters M, Donders R, et al.  Does a regular nurse-led distress screening and discussion improve quality of life of breast cancer patients treated with curative intent? A randomized controlled trial. Psychooncology 2020;29(4):719–728. [DOI] [PubMed] [Google Scholar]
  • 22. Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782–793. [DOI] [PubMed] [Google Scholar]
  • 23. Fitch MI, Ashbury F, Nicoll I. Reflections on the implementation of screening for distress (sixth vital sign) in Canada: key lessons learned. Support Care Cancer. 2018;26(12):4011–4020. [DOI] [PubMed] [Google Scholar]
  • 24. Ehlers SL, Davis K, Bluethmann SM, et al.  Screening for psychosocial distress among patients with cancer: implications for clinical practice, healthcare policy, and dissemination to enhance cancer survivorship. Transl Behav Med. 2019;9(2):282–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Jacobsen PB, Norton WE. The role of implementation science in improving distress assessment and management in oncology: a commentary on “Screening for psychosocial distress among patients with cancer: implications for clinical practice, healthcare policy, and dissemination to enhance cancer survivorship”. Transl Behav Med. 2019;9(2):292–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Lazenby M, Ercolano E, Tan H, et al.  Using the RE-AIM framework for dissemination and implementation of psychosocial distress screening. Eur J Cancer Care (Engl). 2019;28(4):e13036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Knies AK, Jutagir DR, Ercolano E, Pasacreta N, Lazenby M, McCorkle R. Barriers and facilitators to implementing the commission on cancer’s distress screening program standard. Palliat Support Care 2019;17(3):253–261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. McLeod D, Esplen MJ, Wong J, et al.  Enhancing clinical practice in the management of distress: The Therapeutic Practices for Distress Management (TPDM) project. Psychooncology. 2018;27(9):2289–2295. [DOI] [PubMed] [Google Scholar]
  • 29. Fradgley EA, Byrnes E, McCarter K, et al.  A cross-sectional audit of current practices and areas for improvement of distress screening and management in Australian cancer services: is there a will and a way to improve?  Support Care Cancer.  2020;28(1):249–259. [DOI] [PubMed] [Google Scholar]
  • 30. McCarter K, Fradgley EA, Britton B, Tait J, Paul C. Not seeing the forest for the trees: a systematic review of comprehensive distress management programs and implementation strategies. Curr Opin Support Palliat Care. 2020;14(3):220–231. [DOI] [PubMed] [Google Scholar]
  • 31. Bidstrup PE, Johansen C, Mitchell AJ. Screening for cancer-related distress: Summary of evidence from tools to programmes. Acta Oncol. 2011;50(2):194–204. [DOI] [PubMed] [Google Scholar]
  • 32. Dekker J, Braamse A, Schuurhuizen C, et al.  Distress in patients with cancer - on the need to distinguish between adaptive and maladaptive emotional responses. Acta Oncol. 2017;56(7):1026–1029. [DOI] [PubMed] [Google Scholar]
  • 33. Baker-Glenn EA, Park B, Granger L, Symonds P, Mitchell AJ. Desire for psychological support in cancer patients with depression or distress: validation of a simple help question. Psychooncology. 2011;20(5):525–531. [DOI] [PubMed] [Google Scholar]
  • 34. Clover K, Kelly P, Rogers K, Britton B, Carter GL. Predictors of desire for help in oncology outpatients reporting pain or distress. Psychooncology. 2013;22(7):1611–1617. [DOI] [PubMed] [Google Scholar]
  • 35. Funk R, Cisneros C, Williams RC, Kendall J, Hamann HA. What happens after distress screening? Patterns of supportive care service utilization among oncology patients identified through a systematic screening protocol. Support Care Cancer. 2016;24(7):2861–2868. [DOI] [PubMed] [Google Scholar]
  • 36. Dilworth S, Higgins I, Parker V, Kelly B, Turner J. Patient and health professional’s perceived barriers to the delivery of psychosocial care to adults with cancer: a systematic review. Psychooncology. 2014;23(6):601–612. [DOI] [PubMed] [Google Scholar]
  • 37. Tooby J, Cosmides L. The evolutionary psychology of the emotions and their relationship to internal regulatory variables. In: Handbook of Emotions. edn. Edited by Lewis M, Haviland-Jones JM, Feldman Barrett L. New York: The Guilford Press; 2010:114–137. [Google Scholar]
  • 38. Frijda NH.  The Emotions. Cambridge: Cambridge University Press; 1986. [Google Scholar]
  • 39. Bonanno GA, Goorin L, Coifman KG. Sadness and Grief. In: Handbook of Emotions. edn. Edited by Lewis M, Haviland-Jones JM, Feldman Barrett L. New York: The Guilford Press; 2010:797–810. [Google Scholar]
  • 40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5h ed.). Arlington, VA: American Psychiatric Publishing; 2013. [Google Scholar]
  • 41. Dekker J. Adaptive and Maladaptive Emotions in Patients with Cancer: Identification of Indicators and Tailoring of Interventions. In: The 20th World Congress of Psycho-Oncology and Psychosocial Academy. Toronto, Ontario, Canada: International Psycho-Oncology Society; 2018. [Google Scholar]
  • 42. Houben M, Van Den Noortgate W, Kuppens P. The relation between short-term emotion dynamics and psychological well-being: A meta-analysis. Psychol Bull. 2015;141(4):901–930. [DOI] [PubMed] [Google Scholar]
  • 43. Braamse AM, van Meijel B, Visser OJ, Huijgens PC, Beekman AT, Dekker J. Help-seeking behaviour of patients with haematological malignancies treated with autologous stem cell transplantation. Eur J Cancer Care (Engl) 2017;26(5):1–9. doi: 10.1111/ecc.12454. [DOI] [PubMed] [Google Scholar]
  • 44. Clover KA, Mitchell AJ, Britton B, Carter G. Why do oncology outpatients who report emotional distress decline help? Psychooncology. 2015;24(7):812–818. [DOI] [PubMed] [Google Scholar]
  • 45. Steele R, Fitch MI. Why patients with lung cancer do not want help with some needs. Support Care Cancer. 2008;16(3):251–259. [DOI] [PubMed] [Google Scholar]
  • 46. van Scheppingen C, Schroevers MJ, Smink A, et al.  Does screening for distress efficiently uncover meetable unmet needs in cancer patients?  Psychooncology.  2011;20(6):655–663. [DOI] [PubMed] [Google Scholar]
  • 47. Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol. 2012;30(11):1197–1205. [DOI] [PubMed] [Google Scholar]
  • 48. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012;30(11):1187–1196. [DOI] [PubMed] [Google Scholar]
  • 49. Bonanno GA. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol. 2004;59(1):20–28. [DOI] [PubMed] [Google Scholar]
  • 50. Cohen S, Symme SL.  Social Support and Health. San Diego CA: Academic Press; 1985. [Google Scholar]
  • 51. Lepore S. A social–cognitive processing model of emotional adjustment to cancer. In: Psychosocial Interventions for Cancer Edn. Edited by Baum A, Andersen B. Washington, DC: American Psychological Association; 2001:99–116. [Google Scholar]
  • 52. Helgeson VS, Cohen S. Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol. 1996;15(2):135–148. [DOI] [PubMed] [Google Scholar]
  • 53. Siedlecki KL, Salthouse TA, Oishi S, Jeswani S. The relationship between social support and subjective well-being across age. Soc Indic Res. 2014;117(2):561–576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Law E, Levesque JV, Lambert S, Girgis A. The “sphere of care”: a qualitative study of colorectal cancer patient and caregiver experiences of support within the cancer treatment setting. PLoS One. 2018;13(12):e0209436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Hanna G. So you want to be an oncologist? Ulster Med J. 2013;82(1):65. [PMC free article] [PubMed] [Google Scholar]
  • 56. Granek L, Nakash O, Ariad S, Shapira S, Ben-David M. Oncologists’ identification of mental health distress in cancer patients: strategies and barriers. Eur J Cancer Care (Engl). 2018;27(3):e12835. [DOI] [PubMed] [Google Scholar]
  • 57. Granek L, Nakash O, Ben-David M, Shapira S, Ariad S. Oncologists’ treatment responses to mental health distress in their cancer patients. Qual Health Res. 2018;28(11):1735–1745. [DOI] [PubMed] [Google Scholar]
  • 58. Skilbeck J, Payne S. Emotional support and the role of Clinical Nurse Specialists in palliative care. J Adv Nurs. 2003;43(5):521–530. [DOI] [PubMed] [Google Scholar]
  • 59. van den Berg SW, Gielissen MF, Custers JA, van der Graaf WT, Ottevanger PB, Prins JB. BREATH: web-based self-management for psychological adjustment after primary breast cancer–results of a multicenter randomized controlled trial. J Clin Oncol. 2015;33(25):2763–2771. [DOI] [PubMed] [Google Scholar]
  • 60. Post L, Liefbroer AI. Reducing distress in cancer patients—a preliminary evaluation of short-term coaching by expert volunteers. Psychooncology. 2019;28(8):1762–1766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Dekker J, Beekman AT, Boenink AD, et al.  Comment on ‘psychological distress in patients with cancer: is screening the effective solution?’. Br J Cancer. 2013;108(12):2628–2630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Mitchell AJ, Hussain N, Grainger L, Symonds P. Identification of patient-reported distress by clinical nurse specialists in routine oncology practice: a multicentre UK study. Psychooncology. 2011;20(10):1076–1083. [DOI] [PubMed] [Google Scholar]
  • 63. Mitchell AJ, Meader N, Davies E, et al.  Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord. 2012;140(2):149–160. [DOI] [PubMed] [Google Scholar]
  • 64. Syrowatka A, Motulsky A, Kurteva S, et al.  Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat. 2017;165(2):229–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Braamse AM, Gerrits MM, van Meijel B, et al.  Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant. 2012;47(6):757–769. [DOI] [PubMed] [Google Scholar]
  • 66. Gouveia L, Lelorain S, Brédart A, et al.  Oncologists’ perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates. BMC Psychol. 2015;3(1):6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Bauwens S, Baillon C, Distelmans W, Theuns P. Systematic screening for distress in oncology practice using the Distress Barometer: the impact on referrals to psychosocial care. Psychooncology. 2014;23(7):804–811. [DOI] [PubMed] [Google Scholar]
  • 68. Werner A, Stenner C, Schüz J. Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology. 2012;21(8):818–826. [DOI] [PubMed] [Google Scholar]
  • 69. van Linde ME, Braamse AMJ, Collette EH, et al.  Clinical assessment of emotions in patients with cancer: diagnostic accuracy compared with two reference standards. Psychooncology. 2020;29(4):775–780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Granek L, Nakash O, Ariad S, Shapira S, Ben-David M. Mental health distress: oncology nurses’ strategies and barriers in identifying distress in patients with cancer. Clin J Oncol Nurs. 2019;23(1):43–51. [DOI] [PubMed] [Google Scholar]
  • 71. Dekker J, Buurman BM, van der Leeden M. Exercise in people with comorbidity or multimorbidity. Health Psychol. 2019;38(9):822–830. [DOI] [PubMed] [Google Scholar]

Articles from Translational Behavioral Medicine are provided here courtesy of Oxford University Press

RESOURCES